SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CTN'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BU5_A_RBFA301_1 (PROTEIN (FLAVODOXIN)) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 4 / 7 | THR A 463THR A 475GLY A 471ASP A 472 | NoneNoneNoneCTN A 603 (-2.7A) | 0.94A | 1bu5A-3iveA:undetectable | 1bu5A-3iveA:15.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HO5_A_ADNA1604_1 (5'-NUCLEOTIDASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 6 / 11 | GLY A 372ARG A 375PHE A 394ASN A 396PHE A 466ASP A 472 | CTN A 603 (-3.2A)CTN A 603 ( 3.0A)CTN A 603 (-3.5A)CTN A 603 (-3.0A)CTN A 603 (-3.8A)CTN A 603 (-2.7A) | 0.65A | 1ho5A-3iveA:37.3 | 1ho5A-3iveA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HO5_B_ADNB2604_1 (5'-NUCLEOTIDASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 6 / 10 | GLY A 372ARG A 375PHE A 394ASN A 396PHE A 466ASP A 472 | CTN A 603 (-3.2A)CTN A 603 ( 3.0A)CTN A 603 (-3.5A)CTN A 603 (-3.0A)CTN A 603 (-3.8A)CTN A 603 (-2.7A) | 0.51A | 1ho5B-3iveA:37.3 | 1ho5B-3iveA:28.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE1_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASP A 79HIS A 112HIS A 34 | FE A 602 (-2.6A)CTN A 603 ( 3.8A) MN A 601 ( 3.4A) | 0.68A | 1oe1A-3iveA:undetectable | 1oe1A-3iveA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE3_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASP A 79HIS A 112HIS A 34 | FE A 602 (-2.6A)CTN A 603 ( 3.8A) MN A 601 ( 3.4A) | 0.67A | 1oe3A-3iveA:undetectable | 1oe3A-3iveA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG9_A_SAMA385_1 (S-ADENOSYLMETHIONINESYNTHETASE) |
4js1 | BETA-GALACTOSIDEALPHA-2,6-SIALYLTRANSFERASE 1 (Homosapiens) | 4 / 8 | ALA A 190GLU A 342ASP A 339ILE A 328 | CTN A 510 (-3.3A)NoneNoneNone | 0.78A | 1rg9B-4js1A:undetectable | 1rg9B-4js1A:20.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ECP_A_ACRA992_1 (MALTODEXTRINPHOSPHORYLASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 10 | TYR A 342ARG A 229ASP A 472ARG A 375HIS A 34 | NoneNoneCTN A 603 (-2.7A)CTN A 603 ( 3.0A) MN A 601 ( 3.4A) | 1.49A | 2ecpA-3iveA:undetectable | 2ecpA-3iveA:21.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QBN_A_CAMA442_0 (CYTOCHROME P450-CAM) |
3w34 | URIDINE KINASE (Thermusthermophilus) | 4 / 7 | PHE A 65TYR A 43VAL A 165VAL A 173 | NoneCTN A 301 (-4.1A)CTN A 301 ( 4.8A)None | 0.98A | 2qbnA-3w34A:undetectable | 2qbnA-3w34A:20.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RK8_A_PPFA3969_1 (PHOSPHOENOLPYRUVATECARBOXYKINASE,CYTOSOLIC [GTP]) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 4 / 8 | HIS A 116SER A 87ASP A 115ALA A 35 | NoneNoneCTN A 603 ( 4.1A)None | 1.38A | 2rk8A-3iveA:undetectable | 2rk8A-3iveA:22.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_A_CUA1338_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASP A 79HIS A 112HIS A 34 | FE A 602 (-2.6A)CTN A 603 ( 3.8A) MN A 601 ( 3.4A) | 0.69A | 2xxgA-3iveA:undetectable | 2xxgA-3iveA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_C_CUC1339_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASP A 79HIS A 112HIS A 34 | FE A 602 (-2.6A)CTN A 603 ( 3.8A) MN A 601 ( 3.4A) | 0.70A | 2xxgC-3iveA:undetectable | 2xxgC-3iveA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AOD_C_RFPC2002_1 (ACRIFLAVINERESISTANCE PROTEIN B) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | ALA A 352THR A 391ASN A 370GLY A 372LEU A 467 | NoneNoneCTN A 603 (-3.2A)CTN A 603 (-3.2A)None | 1.44A | 3aodC-3iveA:undetectable | 3aodC-3iveA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K13_A_THHA642_1 (5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINEMETHYLTRANSFERASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASN A 396ASP A 115ARG A 229 | CTN A 603 (-3.0A)CTN A 603 ( 4.1A)None | 0.60A | 3k13A-3iveA:undetectable | 3k13A-3iveA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K13_C_THHC643_1 (5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINEMETHYLTRANSFERASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 3 / 3 | ASN A 396ASP A 115ARG A 229 | CTN A 603 (-3.0A)CTN A 603 ( 4.1A)None | 0.85A | 3k13C-3iveA:undetectable | 3k13C-3iveA:21.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N62_A_MTLA870_0 (NITRIC OXIDESYNTHASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 4 / 8 | SER A 177ASN A 396PHE A 466ASP A 469 | CTN A 603 (-4.2A)CTN A 603 (-3.0A)CTN A 603 (-3.8A)None | 1.23A | 3n62A-3iveA:undetectable | 3n62A-3iveA:21.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VNS_A_DVAA602_0 (NRPS ADENYLATIONPROTEIN CYTC1) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 4 / 7 | ASP A 115PHE A 114GLY A 110THR A 82 | CTN A 603 ( 4.1A)NoneNoneNone | 1.13A | 3vnsA-3iveA:undetectable | 3vnsA-3iveA:21.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZTV_A_ADNA1600_1 (NAD NUCLEOTIDASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 6 / 9 | ASN A 370GLY A 372GLY A 373PHE A 394ASN A 396ASP A 472 | CTN A 603 (-3.2A)CTN A 603 (-3.2A)CTN A 603 (-3.3A)CTN A 603 (-3.5A)CTN A 603 (-3.0A)CTN A 603 (-2.7A) | 0.61A | 3ztvA-3iveA:33.3 | 3ztvA-3iveA:28.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A81_A_DXCA1161_0 (MAJOR POLLENALLERGEN BET V 1-A) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | ILE A 109GLY A 78ASP A 79ASP A 115ASN A 120 | NoneNone FE A 602 (-2.6A)CTN A 603 ( 4.1A)None | 0.92A | 4a81A-3iveA:undetectable | 4a81A-3iveA:16.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FU8_A_ACTA302_0 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 4 / 5 | HIS A 112TYR A 342GLN A 219GLY A 372 | CTN A 603 ( 3.8A)NoneNoneCTN A 603 (-3.2A) | 1.28A | 4fu8A-3iveA:undetectable | 4fu8A-3iveA:18.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H2F_A_ADNA601_1 (5'-NUCLEOTIDASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 7 / 9 | ASN A 370GLY A 372GLY A 373ARG A 375PHE A 394PHE A 466ASP A 472 | CTN A 603 (-3.2A)CTN A 603 (-3.2A)CTN A 603 (-3.3A)CTN A 603 ( 3.0A)CTN A 603 (-3.5A)CTN A 603 (-3.8A)CTN A 603 (-2.7A) | 0.39A | 4h2fA-3iveA:35.0 | 4h2fA-3iveA:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H2G_A_ADNA603_1 (5'-NUCLEOTIDASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 7 / 9 | ASN A 370GLY A 372GLY A 373ARG A 375PHE A 394PHE A 466ASP A 472 | CTN A 603 (-3.2A)CTN A 603 (-3.2A)CTN A 603 (-3.3A)CTN A 603 ( 3.0A)CTN A 603 (-3.5A)CTN A 603 (-3.8A)CTN A 603 (-2.7A) | 0.54A | 4h2gA-3iveA:34.8 | 4h2gA-3iveA:28.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KTT_A_SAMA405_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
4js1 | BETA-GALACTOSIDEALPHA-2,6-SIALYLTRANSFERASE 1 (Homosapiens) | 4 / 8 | ALA A 190GLU A 342ASP A 339ILE A 328 | CTN A 510 (-3.3A)NoneNoneNone | 0.77A | 4kttB-4js1A:undetectable | 4kttB-4js1A:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KTT_C_SAMC404_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
4js1 | BETA-GALACTOSIDEALPHA-2,6-SIALYLTRANSFERASE 1 (Homosapiens) | 4 / 8 | ALA A 190GLU A 342ASP A 339ILE A 328 | CTN A 510 (-3.3A)NoneNoneNone | 0.82A | 4kttD-4js1A:undetectable | 4kttD-4js1A:20.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_B_ADNB401_1 (ADENOSINE KINASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | GLY A 373GLY A 372ASN A 370ALA A 217GLY A 471 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)SO4 A 604 (-3.7A)None | 1.02A | 4n09B-3iveA:undetectable | 4n09B-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_B_ADNB401_1 (ADENOSINE KINASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | GLY A 373GLY A 372ASN A 370GLY A 471ASP A 472 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)NoneCTN A 603 (-2.7A) | 0.98A | 4n09B-3iveA:undetectable | 4n09B-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_D_ADND401_1 (ADENOSINE KINASE) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | GLY A 373GLY A 372ASN A 370GLY A 471ASP A 472 | CTN A 603 (-3.3A)CTN A 603 (-3.2A)CTN A 603 (-3.2A)NoneCTN A 603 (-2.7A) | 0.98A | 4n09D-3iveA:undetectable | 4n09D-3iveA:21.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEI_A_SHHA2004_1 (HDAC6 PROTEIN) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | PRO A 395SER A 87HIS A 34GLY A 83HIS A 112 | NoneNone MN A 601 ( 3.4A)NoneCTN A 603 ( 3.8A) | 1.35A | 5eeiA-3iveA:undetectable | 5eeiA-3iveA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEI_B_SHHB801_1 (HDAC6 PROTEIN) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 12 | PRO A 395SER A 87HIS A 34GLY A 83HIS A 112 | NoneNone MN A 601 ( 3.4A)NoneCTN A 603 ( 3.8A) | 1.35A | 5eeiB-3iveA:undetectable | 5eeiB-3iveA:20.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5eexI-3iveA:undetectable5eexJ-3iveA:undetectable | 5eexI-3iveA:10.775eexJ-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5eeyI-3iveA:undetectable5eeyJ-3iveA:undetectable | 5eeyI-3iveA:10.775eeyJ-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5eezI-3iveA:undetectable5eezJ-3iveA:undetectable | 5eezI-3iveA:10.775eezJ-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5ef0I-3iveA:undetectable5ef0J-3iveA:undetectable | 5ef0I-3iveA:10.775ef0J-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5ef1I-3iveA:undetectable5ef1J-3iveA:undetectable | 5ef1I-3iveA:10.775ef1J-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5ef2I-3iveA:undetectable5ef2J-3iveA:undetectable | 5ef2I-3iveA:10.775ef2J-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
3ive | NUCLEOTIDASE (Escherichiacoli) | 5 / 11 | ARG A 375GLY A 92HIS A 116ALA A 35ILE A 95 | CTN A 603 ( 3.0A)NoneNoneNoneNone | 1.21A | 5ef3I-3iveA:undetectable5ef3J-3iveA:undetectable | 5ef3I-3iveA:10.775ef3J-3iveA:10.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FBN_B_SAMB401_0 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) |
4js1 | BETA-GALACTOSIDEALPHA-2,6-SIALYLTRANSFERASE 1 (Homosapiens) | 4 / 7 | ALA A 190GLU A 342ASP A 339ILE A 328 | CTN A 510 (-3.3A)NoneNoneNone | 0.80A | 6fbnA-4js1A:undetectable | 6fbnA-4js1A:20.64 |